ARCHIVES

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Latest Statistics Show Decline In Deaths From Breast Cancer

January 13, 1995

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014

Richard Pazdur’s Comments to ODAC

July 22, 2011

Funding opportunities listed.

November 5, 2004

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

November 5, 2010